Predicting serious problems in adults with sudden pulmonary embolism using CT scan findings
Studies scan and hospital measures to predict worsening in adults with pulmonary embolism.
Key facts
- Who runs it
- Shengjing Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using CTPA.
- Status
- Recruiting
- People taking part
- 300 people, planned
- Started
- 18 Jan 2021
- Expected to end
- 31 Dec 2026
- Type of study
- Observational
- Record updated
- 11 March 2026
Who can take part
The trial is looking for adults with acute pulmonary embolism (a blood clot in the lung arteries) diagnosed by a CT scan of the lung arteries. It studies tests at admission that may predict problems within 30 days.
- Age
- 18 years or older
- Sex
- All sexes
- Disease stage
- Acute pulmonary embolism, diagnosed by CT pulmonary angiography (a CT scan of the lung blood vessels)
- Earlier treatment
- People cannot join if they had reperfusion treatment (treatment to reopen the blocked artery) before admission.
- Main reasons for not taking part
- Pregnancy
- Reperfusion treatment before admission
- Missing CT data
- Missing echocardiography (heart ultrasound) data
- Missing cardiac troponin I (c-Tn I) or NT-pro BNP blood test levels
Show the full registry criteria (4)Hide the full registry criteria
Who can take part
- age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography
Who cannot take part
- missing data regarding CT parameters, echocardiography, cardiac troponin I (c-Tn I), and N-terminal-pro brain natriuretic peptide (NT-pro BNP) levels
- pregnancy
- reception of reperfusion treatment before admission
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Pulmonary embolism and thrombosis
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study collected clinical, laboratory, and CT parameters of acute patients with acute pulmonary embolism from admission to predict adverse outcomes within 30 days after admission into hospital.
The group in the trial
- Acute pulmonary embolism
an age of ≥ 18 years and a PE diagnosis based on CT pulmonary angiography
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Predictive Tool for Predicting Adverse Outcomes in Acute Pulmonary Embolism Patients Using Parameters Obtained by Computed Tomographic Pulmonary Angiography.
- Plain-language title
- Predicting serious problems in adults with sudden pulmonary embolism using CT scan findingsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT05098769, who can take part
- Publications
- Ventricular septum curvature ratio: a novel imaging marker to predict clinical deterioration in normotensive acute pulmonary embolism.Critical care (London, England), 2025
- Predicting Deterioration in Patients With Normotensive Acute Pulmonary Embolism Using Clinical-Imaging Features: A Multicenter Prospective Cohort Study.Journal of the American Heart Association, 2025
- Record updated
- 11 March 2026